2 results match your criteria: "The Affiliated Jinhua Hospital Zhejiang University School of Medicine[Affiliation]"
Comparative efficacy and safety of vedolizumab and antitumor necrosis factor alfa in patients with inflammatory bowel diseases: A meta-analysis.
Acta Pharm
March 2025
Department of Gastroenterology and Hepatology, The Affiliated Jinhua Hospital Zhejiang University School of Medicine, Jinhua 321000, P.R. China.
This meta-analysis directly compares the efficacy and safety of vedolizumab and tumor necrosis factor-α (TNF-α) inhibitors for patients with inflammatory bowel disease (IBD), contrary to the previous one which provided an indirect comparison. In this meta-analysis, only the studies that directly compared two treatments (vedolizumab and TNF-α inhibitors) to each other (head-to-head approach) were considered. A comprehensive literature search was conducted using the following databases: PubMed, Embase, the Cochrane Library, and Web of Science.
View Article and Find Full Text PDFHybrid Versus Conventional Endoscopic Submucosal Dissection for Laterally Spreading Tumors (LSTs): A Retrospective Multicenter Study.
JGH Open
December 2024
Department of Gastroenterology, The Second Affiliated Hospital, College of Medicine Zhejiang University Hangzhou China.
Article Synopsis
- Hybrid ESD is a newer technique gaining attention for treating laterally spreading tumors (LSTs) compared to traditional ESD.
- A study analyzed outcomes from 890 patients who underwent ESD, revealing that hybrid ESD resulted in shorter procedure times and lower hospitalization costs but had a lower R0 resection rate.
- For LSTs sized 10-30 mm, hybrid ESD is a viable option that balances cost savings and operative efficiency without sacrificing resection quality.